Showing 1891-1900 of 4166 results for "".
- NEI's Anterior Segment Initiative has Funded Eight Research Projectshttps://modernod.com/news/neis-anterior-segment-initiative-has-funded-eight-research-projects/2481195/The National Eye Institute's Anterior Segment Initiative has funded eight research projects to explore the innervation of the eye’s surface. The collaborative projects will examine the molecular, morphological, and functional aspects of corneal pain and sensation, and tearing reflexes.
- BMC Virtual Spring Symposium About to Beginhttps://modernod.com/news/bmc-virtual-spring-symposium-to-begin-today/2477844/Bryn Mawr Communications’ virtual educational initiative, the BMC Virtual Spring Symposium, will begin today at 5 pm ET and run to 8:30 pm ET, and will resume tomorrow, May 30, from 10:00 am to 1:35 pm ET. More than 2,000 people have registered for the symposium. For more information
- Johnson & Johnson Vision Showcases New Veritas Vision System and Presents Latest Clinical Data at ESCRS 2021https://modernod.com/news/johnson-johnson-vision-showcases-new-veritas-vision-system-and-presents-latest-clinical-data-at-escrs-2021/2480324/Johnson & Johnson Vision will showcase the new Veritas Vision System and a range of clinical data relating
- Submissions Now Being Accepted for Innovation Stage Speakers and Content for Vision Expo West 2022https://modernod.com/news/submissions-now-being-accepted-for-innovation-stage-speakers-and-content-for-vision-expo-west-2022/2480883/The Vision Council and RX, co-organizers of Vision Expo, announced that submissions are being accepted for Innovation Stage speakers, presentations and panels for
- Oculis Announces Financing to Advance Topical Therapies for Posterior and Anterior Segmentshttps://modernod.com/news/oculis-announces-financing-to-advance-therapies-for-anterior-segment/2479162/Oculis announced that it has closed an oversubscribed $57 million Series C financing. Proceeds from this financing will accelerate Oculis’ strategy with the aim of delivering key goals in the near-term to drive shareholder value and bring transformative therapies to patients. The
- Efficacy of Notal Vision Home OCT Demonstrated by a Series of Scientific and Clinical Workhttps://modernod.com/news/efficacy-of-notal-vision-home-oct-demonstrated-by-a-series-of-scientific-and-clinical-work/2480942/Notal Vision reported that scientific and clinical publications and presentations demonstrate the feasibility and efficacy of their patient-operated, home-based optical coherence tomography (OCT) device. As part of a comprehensive remote monitoring service, which includes a monitoring center and
- Vance Thompson Vision Announces New Clinic and LASIK and Cataract Center in Omahahttps://modernod.com/news/vance-thompson-vision-announces-new-clinic-and-lasik-and-cataract-center-in-omaha/2480189/Vance Thompson Vision is scheduled to open a new clinic in Omeha, Nebraska, in August and will include a focus on cataract surgery, minimally invasive glaucoma surgery, LASIK, and corneal surgery. Brandon Baartman, MD, is an accomplished refractive, cataract,
- First Zeiss Vision Clinic Launched in Mexico City Featuring Integrated Eye Care Modelhttps://modernod.com/news/first-zeiss-vision-clinic-launched-in-mexico-city-featuring-integrated-eye-care-model/2485920/Key Takeaways The Zeiss Vision Clinic is an integrated model combining
- Asclepix Therapeutics Partners With Notal Vision on Home OCT Remote Monitoring in DME and AMD Clinical Trialshttps://modernod.com/news/asclepix-therapeutics-partners-with-notal-vision-on-home-oct-remote-monitoring-in-dme-and-amd-clinical-trials/2478900/Notal Vision announced that the company will provide AsclepiX Therapeutics with Home OCT monitoring services through its Notal Vision Diagnostic Clinic to support AsclepiX’s AXT107 phase 1 clinical trial program. The
- Science Corporation: PRIMA Clinical Trials Show Restoration of "Form Vision"https://modernod.com/news/science-corporation-announces-breakthrough-in-retinal-implant-technology-prima-clinical-trials-show-restoration-of-form-vision/2482509/Science Corporation, a developer in brain-computer interface (BCI) technology, has announced preliminary results from clinical trials of its PRIMA retina implant. This technology has demonstrated the ability to restore what the company is calling 'form vision' in patients suffer